Sung Lee - May 31, 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
EVP, Chief Financial Officer
Signature
/s/ John O. Faurescu, attorney-in-fact for Mr. Lee
Stock symbol
CYTK
Transactions as of
May 31, 2024
Transactions value $
$0
Form type
4
Date filed
6/3/2024, 05:07 PM
Previous filing
Apr 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Award $0 +34.7K $0.00 34.7K May 31, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Award $0 +53.4K $0.00 53.4K May 31, 2024 Common Stock 53.4K $48.51 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Comprised of restricted stock units convertible into shares of common stock on a 1-for-1 basis and vesting as follows: 40% on the 1-year anniversary of the grant date, an additional 40% on the 2-year anniversary of the grant date, and the remaining 20% on the 3-year anniversary of the grant date, in each case subject to the grantee's continued employment.
F2 Comprised of non-statutory stock options to purchase shares of common stock and vesting as follows: 25% on the 1-year anniversary of the grant date and the remaining 75% vesting in equal monthly installments over the subsequent 36 months from the 1-year anniversary of the grant date, in each case subject to continued employment.